Objective: To develop an oral administration to reduce the uric acid in vivo for treatment of hyperuricemia and gout, non-growing E.
目的：制备微囊化不可繁殖型尿酸氧化酶工程菌，以期研制一种降低血尿酸的口服药物，用于治疗高尿酸血症及痛风。
Hyperuricemia is associated with the development and progression of gout, cardiovascular diseases, tumor lysis syndrome and renal disease.
高尿酸血症与痛风、心血管疾病、肿瘤裂解综合征及肾脏疾病的引发或加剧密切相关。
As the biochemical index of gout, hyperuricemia can affect bone, joint, kidney and cardiovascular system.
痛风的生化标志是高尿酸血症，后者不仅可侵犯骨和关节，而且易累及肾脏和心血管系统。
Objective To elucidate the significances of health education in the prevention and treatment of gout and hyperuricemia.
目的探讨健康教育在痛风及高尿酸血症防治中的意义。
Objective To elucidate the significances of health education in the prevention and treatment of gout and hyperuricemia.
目的探讨健康教育在痛风及高尿酸血症防治中的意义。
应用推荐